The Condition PCOS is Now Called PMOS
Researchers and clinicians have renamed polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) to better reflect the condition’s broader hormonal and metabolic impacts and improve patient care.
Affecting an estimated 1 in 8 women worldwide, the condition is associated with irregular menstrual cycles, elevated androgen levels, infertility, and increased risk of Typ…
Fruit-Flavored E-cigarettes for Adults OK'd By FDA
The FDA authorized its first fruit-flavored e-cigarettes for adult smokers, marking a significant shift in federal vaping policy amid declining youth vaping rates, which are now at a 10-year low. The newly authorized products include mango and blueberry flavors and incorporate smartphone-based age verification and Bluetooth access controls intended to reduce youth access.
FDA officials emphas…
Americans Aren't Sleeping Enough
A May 2026 CDC data brief reports that 30.5% of U.S. adults surveyed in 2024 are sleeping fewer than the recommended seven hours per night, a figure largely unchanged since 2020. Sleep insufficiency is clinically associated with cardiometabolic conditions including diabetes, obesity, and cardiovascular disease.
Approximately 15% of adults report difficulty falling asleep and 18% struggle to s…
CDC Data Show Weekly ER Visits for Tick Bites Higher than Usual
CDC's Tick Bite Data Tracker shows weekly emergency department visits for tick bites are currently above historical norms in most U.S. regions, with rates in all areas except the South Central U.S. at their highest for this time of year since 2017.
CDC is urging preventive measures ahead of Lyme Disease Awareness Month in May, citing risks of Lyme disease, Rocky Mountain spotted fever, and alpha-gal syndrome. Recommended actions include EPA-registered repellents, permethrin-treated clothing, and routine tick checks. Prompt tick removal — within 24 hours — is identified as a key interventi…
CDC Reports Emergence of Extensively Drug-Resistant Shigella
CDC analysis published in MMWR reports a marked rise in extensively drug-resistant (XDR) Shigella infections in the United States. Among 16,788 isolates collected from 2011–2023, 3% were XDR, increasing from 0% in 2011–2015 to 8.5% in 2023.
Most cases occurred in adult men, with limited travel history, suggesting domestic transmission. XDR strains are resistant to five key antibiotics, and no FDA-approved oral treatments are available.
CDC highlights the need for strengthened surveillance, antimicrobial susceptibility testing, and rapid reporting, along with targeted prevention strategi…